Instem Taps ex-Novartis Head of Emerging Technologies to Put Science Behind Practical AI and NAMs

Contributed by: Business Wire

Logo

Tags

Software

Research

Professional Services

Pharmaceutical

Technology

Artificial Intelligence

Health Technology

Data Analytics

Clinical Trials

Science

Biotechnology

FDA

Health

Szczepan Baran

More Like This

Instem Strengthens Commitment to End-to-End Preclinical Platform Amid Regulatory Evolution

Instem Now Part of ARCHIMED to Further Accelerate Growth and Impact

Instem Unveils New Global Headquarters in Boston, MA

Instem achieves a major milestone, acquires all shares of Xybion from Banerjee Group LLC controlled by Dr. Pradip K. Banerjee

INSTEM Announces Extension of Research Collaboration Agreement with U.S. FDA to 2031

Health Tech Company Intelligencia AI Appoints Scientific Advisory Board Chair

Instem Announces Provantis® 12: A Powerful Step Forward in Preclinical Study Management

Exscientia Appoints New Leaders to Strengthen the Impact of Integrated Technologies and Focus Clinical Development Expertise in Oncology